Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company engaged in the research, development, and manufacturing of innovative pharmaceutical products. The company focuses on biopharmaceutical products across several therapeutic areas, including oncology, autoimmune diseases, and infectious diseases, aiming to offer advanced solutions for critical healthcare challenges. Sichuan Kelun-Biotech operates within the biotech industry, leveraging cutting-edge technologies like monoclonal antibodies and biological drugs to develop treatments that address unmet medical needs.

Situated in a rapidly expanding sector, the company plays a significant role in advancing medical innovations that contribute to global health improvements. It collaborates with international partners and researchers to drive breakthroughs in drug development and expand the accessibility of vital medicines. Sichuan Kelun-Biotech's efforts in biotechnological research and development underscore its contribution to the biopharmaceutical landscape, making it a pivotal entity in the pursuit of enhancing therapeutic options and patient outcomes worldwide.